Prognosis of immune checkpoint inhibitor-related myocarditis: Retrospective experience of a single institution

Myocarditis related to immune checkpoint inhibitors (ICIs) treatment is a rare but potentially life-threatening adverse event. To gain insight into this condition, we analyzed the clinical characteristics and prognosis of patients with ICI-related myocarditis.